Migraine Minute News Update 11.10.23: Veterans are disproportionately impacted by headache disorders
Release Date: 11/10/2023
FDA Approves Axsome’s New Migraine Drug Symbravo®
Migraine Minute News Update
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O’Brien has the details and when it becomes available in this Migraine Minute News update. Learn More:
info_outline
Can CGRP Blocking Drugs Help Endometriosis?
Migraine Minute News Update
Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O’Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month. Read More: https://bit.ly/4jp0cG2 AMD Comorbidities Library: https://bit.ly/3CIrLtd
info_outline
Cluster Headache Often Coexists with Fibromyalgia & Migraine
Migraine Minute News Update
Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O’Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions. Learn More:
info_outline
Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
Migraine Minute News Update
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O’Brien has the details in this Migraine Minute News Update. Read More: https://bit.ly/3BY2J9d
info_outline
FDA Clears Nerivio Device for Children 8+
Migraine Minute News Update
Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O’Brien explains the FDA clearance of Theranica’s Nerivio device for acute and preventive migraine treatment in kids. Read more:
info_outline
MERTK as a Potential Novel Target for Cluster Headache
Migraine Minute News Update
Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache. In this Migraine Minute News Update Molly O’Brien breaks down what it means for people living with Cluster. Read More:
info_outline
No Link Between Migraine and Risk of Parkinson’s Disease
Migraine Minute News Update
Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson’s disease. Molly O’Brien explains in this Migraine Minute News Update. Want to know more about Migraine and Parkinson’s disease? Check out this article in AMD’s Comorbidities library:
info_outline
New Treatment Targets PACAP for Migraine Prevention
Migraine Minute News Update
A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo. In this Migraine Minute News Update Molly O’Brien explains. Read More:
info_outline
NINDS Funds Research on the Link Between Headache Disorders & the Circadian Clock
Migraine Minute News Update
The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O’Brien has details in this Migraine Minute News Update. Read more: bit.ly/3BsNwfT
info_outline
Can CGRP blockers impact blood pressure in people over 60?
Migraine Minute News Update
A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O’Brien explains the findings. Read More: bit.ly/3zpcYSB
info_outlineAs we honor and celebrate those who have and continue to serve our country on Veterans Day, the Association of Migraine Disorders wants to raise awareness about how headache disorders affect those who serve. To our brave service members, thank you.
Learn more about how headache impacts Veterans and services the VA offers: